FDA is under scrutiny for the baby formula crisis

The FDA commissioner came under scrutiny in the House Ag Committee over the baby formula shortage.

Lawmakers blamed the Agency for not acting fast enough and also pointed to concentration in the market by the Abbott Nutrition plant that remains shut down.

Congress sent a bill to the President’s desk that would allow USDA to waive requirements on formula purchases through WIC.

A separate measure that would direct $28 million in emergency funding to the FDA faces an uncertain future. The Abbott Plant could slowly come back online next week.


FDA Sued Over Biotech Salmon Records

FDA’s new blueprint for a safer food system